DNA is the blueprint of life. Genes encode proteins and serve as the body's basic components. However, building a functioning ...

The broader biotechnology sector is experiencing notable volatility, but one company remains conspicuously quiet. Aravive Inc. has entered a phase of complete i ...

Eli Lilly is continuing a run of dealmaking to strengthen its genetic medicine offering by penning a pact with gene editing company Seamless Therapeutics. This morning’s deal with Seamless centers on ...

This past spring, a biotech company announced the first use of a new gene-editing technology in people to fix an errant gene that causes a severe immune disorder. In June, a baby born with a ...

Directors, and brothers, Lauris and Raitis Abele discuss their provocative and edgy takedown of dogmatic thinking and how its appeal has transcended the genre audience. By Georg Szalai Global Business ...

HANOI/SINGAPORE, Nov 19 (Reuters) - Vietnam-founded biotechnology firm Gene Solutions plans to raise $100 million through a pre-IPO round and a potential listing as soon as 2026, capitalising on ...

New research suggests a genetic dynamic that may have contributed to Neanderthals' extinction. Neanderthal-Museum, Mettmann CC BY-SA 4.0 via Wikimedia Commons Did interbreeding between humans and ...

Advanced biotechnology repurposes two bacterial immune systems to correct large stretches of DNA. Human cells that have been edited with the new retron-based gene editing technology. Orange dots mark ...

"In fact, assisted gene flow has been successful in boosting resilience across many animal species and may offer a critical lifeline for struggling coral populations." Coral reefs worldwide are under ...

Julian McMahon remembered by Alyssa Milano, former costars: 'Losing him feels unreal' Jeffrey Epstein died by suicide and there’s no ‘client list,’ Justice Department says Julie Bowen Thought ‘Happy ...

Corresponding author Akshay Sharma, MBBS, MSc, St. Jude Department of Bone Marrow Transplantation and Cellular Therapy talks to St. Jude patient enrolled on the reported clinical trial, Corey Luellen.